UK markets closed

Ono Pharmaceutical Co., Ltd. (ON4.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
13.10+0.10 (+0.77%)
As of 03:29PM CEST. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/03/2023
31/03/2022
31/03/2021
31/03/2020
Total revenue
502,672,000
447,187,000
361,361,000
309,284,000
292,420,000
Cost of revenue
127,126,000
110,062,000
93,511,000
85,573,000
79,063,000
Gross profit
375,547,000
337,124,000
267,850,000
223,711,000
213,356,000
Operating expenses
Research development
112,174,000
95,344,000
75,879,000
62,384,000
66,497,000
Selling general and administrative
100,270,000
89,486,000
77,057,000
69,230,000
67,679,000
Total operating expenses
215,611,000
195,161,000
164,654,000
125,381,000
135,866,000
Operating income or loss
159,936,000
141,963,000
103,196,000
98,330,000
77,490,000
Interest expense
229,000
913,000
874,000
137,000
845,000
Income before tax
163,734,000
143,532,000
105,025,000
100,890,000
79,696,000
Income tax expense
35,694,000
30,619,000
24,340,000
25,392,000
19,808,000
Income from continuing operations
128,040,000
112,913,000
80,685,000
75,498,000
59,888,000
Net income
127,977,000
112,723,000
80,519,000
75,425,000
59,704,000
Net income available to common shareholders
127,977,000
112,723,000
80,519,000
75,425,000
59,704,000
Basic EPS
256.51
230.85
162.19
151.11
118.47
Diluted EPS
256.45
230.79
162.16
151.09
118.45
Basic average shares
487,068
488,300
496,459
499,137
503,975
Diluted average shares
487,107
488,353
496,527
499,203
504,044